SlideShare une entreprise Scribd logo
1  sur  20
Non-Hodgkin’sNon-Hodgkin’s
LymphomaLymphoma
Michael HakimMichael Hakim
Bio 316Bio 316
August 5, 2004August 5, 2004
LymphomaLymphoma
 History and OverviewHistory and Overview
 StatisticsStatistics
 What it effects (biology)What it effects (biology)
 Classification and StagingClassification and Staging
 SymptomsSymptoms
 Causes and Risk FactorsCauses and Risk Factors
 Diagnosis and TreatmentDiagnosis and Treatment
Lymphoma’sLymphoma’s
Where They BeginWhere They Begin
 Lymphomas are aLymphomas are a
cancer of thecancer of the
lymphatic systemlymphatic system
• Lymphatic vesselsLymphatic vessels
• Lymph nodesLymph nodes
(underarms, groin,(underarms, groin,
neck, spleen,neck, spleen,
tonsils and bonetonsils and bone
marrow)marrow)
Lymphoma’sLymphoma’s
Where They BeginWhere They Begin
 The Lymphatic system is our bodiesThe Lymphatic system is our bodies
main fight against infectionmain fight against infection
 Lymphocytes (B-cell and T-cell)Lymphocytes (B-cell and T-cell)
• Carried through our lymphatic systemCarried through our lymphatic system
and help our bodies fight infectionand help our bodies fight infection
• Lymphocytes are carried through theLymphocytes are carried through the
lymph vessels as well as the bloodlymph vessels as well as the blood
stream, so cancer can start in nodes andstream, so cancer can start in nodes and
spread anywhere throughout the body.spread anywhere throughout the body.
Lymphatic SystemLymphatic System
American Medical
Association
Non-Hodgkin’s LymphomaNon-Hodgkin’s Lymphoma
StatisticsStatistics
for 2004for 2004
 54,370 new cases54,370 new cases
 19,410 deaths19,410 deaths
• In California Alone there are est. 5,550 newIn California Alone there are est. 5,550 new
cases and a Death rate of 1,730 (California hascases and a Death rate of 1,730 (California has
the highest incidence and Death rate for Non-the highest incidence and Death rate for Non-
Hodgkin’s LymphomaHodgkin’s Lymphoma
• Non-Hodgkin’s Lymphoma is the 6Non-Hodgkin’s Lymphoma is the 6thth
and 7and 7thth
most deadly cancers for men and womenmost deadly cancers for men and women
• Recent studies have shown that overweightRecent studies have shown that overweight
patients are more likely to die then thosepatients are more likely to die then those
patients who are in better shape.patients who are in better shape.
ClassificationClassification
 Usually classified by how the cellsUsually classified by how the cells
look under a microscope and howlook under a microscope and how
quickly they grow and spreadquickly they grow and spread
• Aggressive lymphomas (high-gradeAggressive lymphomas (high-grade
lymphomas)lymphomas)
• Indolent Lymphomas (low-gradeIndolent Lymphomas (low-grade
lymphomas)lymphomas)
Non-Hodgkin’s LymphomaNon-Hodgkin’s Lymphoma
StagingStaging
 Stage is the term used to describe theStage is the term used to describe the
extent of tumor that has spread throughextent of tumor that has spread through
the body( I and II are localized where asthe body( I and II are localized where as
III and IV are advanced.III and IV are advanced.
 Each stage is then divided into categoriesEach stage is then divided into categories
A, B, and EA, B, and E
• A: No systemic symptomsA: No systemic symptoms
• B: Systemic Symptoms such as fever, nightB: Systemic Symptoms such as fever, night
sweats and weight losssweats and weight loss
• E: Spreading of disease from lymph node toE: Spreading of disease from lymph node to
another organanother organ
StagingStaging
Non-Hodgkin’s LymphomaNon-Hodgkin’s Lymphoma
 Two main types of Non-Hodgkin’sTwo main types of Non-Hodgkin’s
Lymphoma:Lymphoma:
 B-Cell and T-Cell LymphomasB-Cell and T-Cell Lymphomas
•B-Cell lymphomas (80%)B-Cell lymphomas (80%)
•T-Cell lymphomas (15%)T-Cell lymphomas (15%)
B-Cell Lymphoma (80%)B-Cell Lymphoma (80%)
 B-Cells help make antibodies, which areB-Cells help make antibodies, which are
proteins that attach to and help destroyproteins that attach to and help destroy
antigensantigens
 Lymphomas are caused when a mutationLymphomas are caused when a mutation
arises during the B-cell life cyclearises during the B-cell life cycle
 Various different lymphomas can occurVarious different lymphomas can occur
during several different stages of the cycleduring several different stages of the cycle
• Follicular lymphoma, which is a type of B-cellFollicular lymphoma, which is a type of B-cell
lymphoma is caused by a gene translocationlymphoma is caused by a gene translocation
which results in an over expressed gene calledwhich results in an over expressed gene called
BCL-2, which blocks apoptosis.BCL-2, which blocks apoptosis.
B-Cell CancersB-Cell Cancers
T-Cell Lymphoma (15%)T-Cell Lymphoma (15%)
 The T-cells are born from stem cells,The T-cells are born from stem cells,
similar to that of B-cells, but maturesimilar to that of B-cells, but mature
in the thymus.in the thymus.
 They help the immune system workThey help the immune system work
in a coordinated fashion.in a coordinated fashion.
• These types of lymphomas areThese types of lymphomas are
categorized by how the cell is affectedcategorized by how the cell is affected
 Anaplastic Large cell Lymphoma, t-cellAnaplastic Large cell Lymphoma, t-cell
lymphoma caused by a gene translocation inlymphoma caused by a gene translocation in
chromosome 5chromosome 5
Lymphoma.org
SymptomsSymptoms
 Painful Swelling of lymph nodesPainful Swelling of lymph nodes
located in the neck, underarm andlocated in the neck, underarm and
groin.groin.
 Unexplained FeverUnexplained Fever
 Night SweatsNight Sweats
 Constant FatigueConstant Fatigue
 Unexplained Weight lossUnexplained Weight loss
 Itchy SkinItchy Skin
Cancer Sourcebook
Causes and Risk FactorsCauses and Risk Factors
 The Exact causes are still unknownThe Exact causes are still unknown
• Higher risk for individuals who:Higher risk for individuals who:
 Exposed to chemicals such as pesticides orExposed to chemicals such as pesticides or
solventssolvents
 Infected w/ Epstein-Barr VirusInfected w/ Epstein-Barr Virus
 Family history of NHL (although noFamily history of NHL (although no
hereditary pattern has been established)hereditary pattern has been established)
 Infected w/ Human Immunodeficiency VirusInfected w/ Human Immunodeficiency Virus
(HIV)(HIV)
Lymphoma.org
DiagnosisDiagnosis
 X-RaysX-Rays
 CT scansCT scans
 Magnetic Resonance Imaging (MRI)Magnetic Resonance Imaging (MRI)
 BiopsyBiopsy
 LymphangiogramLymphangiogram
• Pictures of the lymphatic system takenPictures of the lymphatic system taken
w/ x-ray after a special dye is injectedw/ x-ray after a special dye is injected
to illuminate lymph nodes and vesselsto illuminate lymph nodes and vessels
TreatmentTreatment
 Non-Hodgkin’s Lymphoma is usuallyNon-Hodgkin’s Lymphoma is usually
treated by a team of physicians includingtreated by a team of physicians including
hematologists, medical oncologists and ahematologists, medical oncologists and a
radiation oncologist.radiation oncologist.
 In some cases such as for IndolentIn some cases such as for Indolent
lymphomas, the Doctor may wait to startlymphomas, the Doctor may wait to start
treatment until the patient starts showingtreatment until the patient starts showing
symptoms, known as “watchful waiting”symptoms, known as “watchful waiting”
Treatment OptionsTreatment Options
 ChemotherapyChemotherapy
 RadiationRadiation
 Bone Marrow TransplantationBone Marrow Transplantation
 SurgerySurgery
 Bortezomib (Velcade)Bortezomib (Velcade)
 ImmunotherapyImmunotherapy
 Using the bodies own immune systemUsing the bodies own immune system
combined with material made in a lab.combined with material made in a lab.
Survival RatesSurvival Rates
 Survival Rates vary widely by cellSurvival Rates vary widely by cell
type and staging.type and staging.
• 1 Year Survival Rate: 77%1 Year Survival Rate: 77%
• 5 Year Survival Rate: 56%5 Year Survival Rate: 56%
• 10 Year Survival Rate: 42%10 Year Survival Rate: 42%
Cancer.org
Any Questions?Any Questions?

Contenu connexe

Tendances (20)

Burkitt lymphoma.ppt
Burkitt lymphoma.pptBurkitt lymphoma.ppt
Burkitt lymphoma.ppt
 
Skin cancers
Skin cancersSkin cancers
Skin cancers
 
Hodgkins lymphoma
Hodgkins lymphomaHodgkins lymphoma
Hodgkins lymphoma
 
Esophageal ca
Esophageal caEsophageal ca
Esophageal ca
 
non-hodgkin’s-lymphoma
non-hodgkin’s-lymphomanon-hodgkin’s-lymphoma
non-hodgkin’s-lymphoma
 
Colorectal Cancer
Colorectal CancerColorectal Cancer
Colorectal Cancer
 
Vascular tumors 8
Vascular tumors 8Vascular tumors 8
Vascular tumors 8
 
Breast cancer staging
Breast cancer stagingBreast cancer staging
Breast cancer staging
 
FEMALE GENITAL SYSTEM PATHOLOGY
FEMALE GENITAL SYSTEM PATHOLOGYFEMALE GENITAL SYSTEM PATHOLOGY
FEMALE GENITAL SYSTEM PATHOLOGY
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Childhood tumours
Childhood tumoursChildhood tumours
Childhood tumours
 
Carcinoma Of Thyroid Gland
Carcinoma Of Thyroid GlandCarcinoma Of Thyroid Gland
Carcinoma Of Thyroid Gland
 
Uterus pathology
Uterus pathology Uterus pathology
Uterus pathology
 
Hodgkin lymphoma
Hodgkin lymphomaHodgkin lymphoma
Hodgkin lymphoma
 
Vaginal & cervical carcinoma
Vaginal & cervical carcinomaVaginal & cervical carcinoma
Vaginal & cervical carcinoma
 
Non hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhuNon hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhu
 
Surgical Infection. Acute purulent infection of skin & cellular spases
Surgical Infection. Acute purulent infection of skin & cellular spasesSurgical Infection. Acute purulent infection of skin & cellular spases
Surgical Infection. Acute purulent infection of skin & cellular spases
 
04. thyroid tumors
04. thyroid tumors04. thyroid tumors
04. thyroid tumors
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Myoma
MyomaMyoma
Myoma
 

Similaire à Non hodgkins lymphoma

Similaire à Non hodgkins lymphoma (20)

Nhl
NhlNhl
Nhl
 
Non-Hodgkins Lymphoma management and staging.ppt
Non-Hodgkins Lymphoma management and staging.pptNon-Hodgkins Lymphoma management and staging.ppt
Non-Hodgkins Lymphoma management and staging.ppt
 
Lymphoma and pancytopenia
Lymphoma and pancytopeniaLymphoma and pancytopenia
Lymphoma and pancytopenia
 
Lymphoma Treatment India
Lymphoma Treatment IndiaLymphoma Treatment India
Lymphoma Treatment India
 
Lymphomas 1-nhl
Lymphomas 1-nhlLymphomas 1-nhl
Lymphomas 1-nhl
 
Lymphomas 5
Lymphomas 5Lymphomas 5
Lymphomas 5
 
Lymphoma new
Lymphoma newLymphoma new
Lymphoma new
 
Lymphomas3
Lymphomas3Lymphomas3
Lymphomas3
 
Geeta hodgkin lymphoma
Geeta  hodgkin lymphomaGeeta  hodgkin lymphoma
Geeta hodgkin lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
lymphoma 16-3-2023 dr masoud.ppt
lymphoma 16-3-2023 dr masoud.pptlymphoma 16-3-2023 dr masoud.ppt
lymphoma 16-3-2023 dr masoud.ppt
 
Lymphoma Medical surgical nursing..).pdf
Lymphoma Medical surgical nursing..).pdfLymphoma Medical surgical nursing..).pdf
Lymphoma Medical surgical nursing..).pdf
 
Lymphoma
Lymphoma Lymphoma
Lymphoma
 
lymphomas(L).ppt
lymphomas(L).pptlymphomas(L).ppt
lymphomas(L).ppt
 
lymphomas(L).ppt
lymphomas(L).pptlymphomas(L).ppt
lymphomas(L).ppt
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Hematology
HematologyHematology
Hematology
 
lymphoid neoplasms ppt.pptx
lymphoid neoplasms ppt.pptxlymphoid neoplasms ppt.pptx
lymphoid neoplasms ppt.pptx
 
lymphoma (1).pptx
lymphoma (1).pptxlymphoma (1).pptx
lymphoma (1).pptx
 
35341
3534135341
35341
 

Plus de Chandan N

Universal & transmission precaution
Universal & transmission precautionUniversal & transmission precaution
Universal & transmission precautionChandan N
 
Coronory angiography
Coronory angiographyCoronory angiography
Coronory angiographyChandan N
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpbChandan N
 
Reducing stroke in AF
Reducing stroke in AFReducing stroke in AF
Reducing stroke in AFChandan N
 
Antiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisAntiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisChandan N
 
Anticoagulant in DVT and APE
Anticoagulant in DVT and APEAnticoagulant in DVT and APE
Anticoagulant in DVT and APEChandan N
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse Chandan N
 
Renal failure
Renal failureRenal failure
Renal failureChandan N
 
Final housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureFinal housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureChandan N
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancyChandan N
 
Control and prevention_of_influenza
Control and prevention_of_influenzaControl and prevention_of_influenza
Control and prevention_of_influenzaChandan N
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failureChandan N
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatmentChandan N
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failureChandan N
 
Abnormal puerperium
Abnormal puerperiumAbnormal puerperium
Abnormal puerperiumChandan N
 
non-hodgkin’s-lymphoma
non-hodgkin’s-lymphomanon-hodgkin’s-lymphoma
non-hodgkin’s-lymphomaChandan N
 

Plus de Chandan N (20)

Universal & transmission precaution
Universal & transmission precautionUniversal & transmission precaution
Universal & transmission precaution
 
Coronory angiography
Coronory angiographyCoronory angiography
Coronory angiography
 
Anasthesia during cpb
Anasthesia during cpbAnasthesia during cpb
Anasthesia during cpb
 
Reducing stroke in AF
Reducing stroke in AFReducing stroke in AF
Reducing stroke in AF
 
Antiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosisAntiplatelet and arterial thrombosis
Antiplatelet and arterial thrombosis
 
Anticoagulant in DVT and APE
Anticoagulant in DVT and APEAnticoagulant in DVT and APE
Anticoagulant in DVT and APE
 
Antibiotics use and overuse
Antibiotics use and overuse Antibiotics use and overuse
Antibiotics use and overuse
 
Acute mi
Acute miAcute mi
Acute mi
 
Renal failure
Renal failureRenal failure
Renal failure
 
Nutrition
NutritionNutrition
Nutrition
 
ckd
ckdckd
ckd
 
Final housestaff opportunistic infections lecture
Final housestaff opportunistic infections lectureFinal housestaff opportunistic infections lecture
Final housestaff opportunistic infections lecture
 
Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
Control and prevention_of_influenza
Control and prevention_of_influenzaControl and prevention_of_influenza
Control and prevention_of_influenza
 
Chronic renal failure
Chronic renal failureChronic renal failure
Chronic renal failure
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Abnormal puerperium
Abnormal puerperiumAbnormal puerperium
Abnormal puerperium
 
non-hodgkin’s-lymphoma
non-hodgkin’s-lymphomanon-hodgkin’s-lymphoma
non-hodgkin’s-lymphoma
 
HIV
HIVHIV
HIV
 

Dernier

TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYDRPREETHIJAMESP
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFShahid Hussain
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPupayumnam1
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSuresh Kumar K
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryDr Simran Deepak Vangani
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadNephroTube - Dr.Gawad
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...marcuskenyatta275
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentabdeli bhadarva
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 

Dernier (20)

TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
PREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptxPREPARATION FOR EXAMINATION FON II .pptx
PREPARATION FOR EXAMINATION FON II .pptx
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
TEST BANK For Lewis's Medical Surgical Nursing in Canada, 4th Edition by Jane...
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 

Non hodgkins lymphoma

  • 2. LymphomaLymphoma  History and OverviewHistory and Overview  StatisticsStatistics  What it effects (biology)What it effects (biology)  Classification and StagingClassification and Staging  SymptomsSymptoms  Causes and Risk FactorsCauses and Risk Factors  Diagnosis and TreatmentDiagnosis and Treatment
  • 3. Lymphoma’sLymphoma’s Where They BeginWhere They Begin  Lymphomas are aLymphomas are a cancer of thecancer of the lymphatic systemlymphatic system • Lymphatic vesselsLymphatic vessels • Lymph nodesLymph nodes (underarms, groin,(underarms, groin, neck, spleen,neck, spleen, tonsils and bonetonsils and bone marrow)marrow)
  • 4. Lymphoma’sLymphoma’s Where They BeginWhere They Begin  The Lymphatic system is our bodiesThe Lymphatic system is our bodies main fight against infectionmain fight against infection  Lymphocytes (B-cell and T-cell)Lymphocytes (B-cell and T-cell) • Carried through our lymphatic systemCarried through our lymphatic system and help our bodies fight infectionand help our bodies fight infection • Lymphocytes are carried through theLymphocytes are carried through the lymph vessels as well as the bloodlymph vessels as well as the blood stream, so cancer can start in nodes andstream, so cancer can start in nodes and spread anywhere throughout the body.spread anywhere throughout the body.
  • 6. Non-Hodgkin’s LymphomaNon-Hodgkin’s Lymphoma StatisticsStatistics for 2004for 2004  54,370 new cases54,370 new cases  19,410 deaths19,410 deaths • In California Alone there are est. 5,550 newIn California Alone there are est. 5,550 new cases and a Death rate of 1,730 (California hascases and a Death rate of 1,730 (California has the highest incidence and Death rate for Non-the highest incidence and Death rate for Non- Hodgkin’s LymphomaHodgkin’s Lymphoma • Non-Hodgkin’s Lymphoma is the 6Non-Hodgkin’s Lymphoma is the 6thth and 7and 7thth most deadly cancers for men and womenmost deadly cancers for men and women • Recent studies have shown that overweightRecent studies have shown that overweight patients are more likely to die then thosepatients are more likely to die then those patients who are in better shape.patients who are in better shape.
  • 7. ClassificationClassification  Usually classified by how the cellsUsually classified by how the cells look under a microscope and howlook under a microscope and how quickly they grow and spreadquickly they grow and spread • Aggressive lymphomas (high-gradeAggressive lymphomas (high-grade lymphomas)lymphomas) • Indolent Lymphomas (low-gradeIndolent Lymphomas (low-grade lymphomas)lymphomas)
  • 8. Non-Hodgkin’s LymphomaNon-Hodgkin’s Lymphoma StagingStaging  Stage is the term used to describe theStage is the term used to describe the extent of tumor that has spread throughextent of tumor that has spread through the body( I and II are localized where asthe body( I and II are localized where as III and IV are advanced.III and IV are advanced.  Each stage is then divided into categoriesEach stage is then divided into categories A, B, and EA, B, and E • A: No systemic symptomsA: No systemic symptoms • B: Systemic Symptoms such as fever, nightB: Systemic Symptoms such as fever, night sweats and weight losssweats and weight loss • E: Spreading of disease from lymph node toE: Spreading of disease from lymph node to another organanother organ
  • 10. Non-Hodgkin’s LymphomaNon-Hodgkin’s Lymphoma  Two main types of Non-Hodgkin’sTwo main types of Non-Hodgkin’s Lymphoma:Lymphoma:  B-Cell and T-Cell LymphomasB-Cell and T-Cell Lymphomas •B-Cell lymphomas (80%)B-Cell lymphomas (80%) •T-Cell lymphomas (15%)T-Cell lymphomas (15%)
  • 11. B-Cell Lymphoma (80%)B-Cell Lymphoma (80%)  B-Cells help make antibodies, which areB-Cells help make antibodies, which are proteins that attach to and help destroyproteins that attach to and help destroy antigensantigens  Lymphomas are caused when a mutationLymphomas are caused when a mutation arises during the B-cell life cyclearises during the B-cell life cycle  Various different lymphomas can occurVarious different lymphomas can occur during several different stages of the cycleduring several different stages of the cycle • Follicular lymphoma, which is a type of B-cellFollicular lymphoma, which is a type of B-cell lymphoma is caused by a gene translocationlymphoma is caused by a gene translocation which results in an over expressed gene calledwhich results in an over expressed gene called BCL-2, which blocks apoptosis.BCL-2, which blocks apoptosis.
  • 13. T-Cell Lymphoma (15%)T-Cell Lymphoma (15%)  The T-cells are born from stem cells,The T-cells are born from stem cells, similar to that of B-cells, but maturesimilar to that of B-cells, but mature in the thymus.in the thymus.  They help the immune system workThey help the immune system work in a coordinated fashion.in a coordinated fashion. • These types of lymphomas areThese types of lymphomas are categorized by how the cell is affectedcategorized by how the cell is affected  Anaplastic Large cell Lymphoma, t-cellAnaplastic Large cell Lymphoma, t-cell lymphoma caused by a gene translocation inlymphoma caused by a gene translocation in chromosome 5chromosome 5 Lymphoma.org
  • 14. SymptomsSymptoms  Painful Swelling of lymph nodesPainful Swelling of lymph nodes located in the neck, underarm andlocated in the neck, underarm and groin.groin.  Unexplained FeverUnexplained Fever  Night SweatsNight Sweats  Constant FatigueConstant Fatigue  Unexplained Weight lossUnexplained Weight loss  Itchy SkinItchy Skin Cancer Sourcebook
  • 15. Causes and Risk FactorsCauses and Risk Factors  The Exact causes are still unknownThe Exact causes are still unknown • Higher risk for individuals who:Higher risk for individuals who:  Exposed to chemicals such as pesticides orExposed to chemicals such as pesticides or solventssolvents  Infected w/ Epstein-Barr VirusInfected w/ Epstein-Barr Virus  Family history of NHL (although noFamily history of NHL (although no hereditary pattern has been established)hereditary pattern has been established)  Infected w/ Human Immunodeficiency VirusInfected w/ Human Immunodeficiency Virus (HIV)(HIV) Lymphoma.org
  • 16. DiagnosisDiagnosis  X-RaysX-Rays  CT scansCT scans  Magnetic Resonance Imaging (MRI)Magnetic Resonance Imaging (MRI)  BiopsyBiopsy  LymphangiogramLymphangiogram • Pictures of the lymphatic system takenPictures of the lymphatic system taken w/ x-ray after a special dye is injectedw/ x-ray after a special dye is injected to illuminate lymph nodes and vesselsto illuminate lymph nodes and vessels
  • 17. TreatmentTreatment  Non-Hodgkin’s Lymphoma is usuallyNon-Hodgkin’s Lymphoma is usually treated by a team of physicians includingtreated by a team of physicians including hematologists, medical oncologists and ahematologists, medical oncologists and a radiation oncologist.radiation oncologist.  In some cases such as for IndolentIn some cases such as for Indolent lymphomas, the Doctor may wait to startlymphomas, the Doctor may wait to start treatment until the patient starts showingtreatment until the patient starts showing symptoms, known as “watchful waiting”symptoms, known as “watchful waiting”
  • 18. Treatment OptionsTreatment Options  ChemotherapyChemotherapy  RadiationRadiation  Bone Marrow TransplantationBone Marrow Transplantation  SurgerySurgery  Bortezomib (Velcade)Bortezomib (Velcade)  ImmunotherapyImmunotherapy  Using the bodies own immune systemUsing the bodies own immune system combined with material made in a lab.combined with material made in a lab.
  • 19. Survival RatesSurvival Rates  Survival Rates vary widely by cellSurvival Rates vary widely by cell type and staging.type and staging. • 1 Year Survival Rate: 77%1 Year Survival Rate: 77% • 5 Year Survival Rate: 56%5 Year Survival Rate: 56% • 10 Year Survival Rate: 42%10 Year Survival Rate: 42% Cancer.org